Luz, Martim
Torres, Tiago https://orcid.org/0000-0003-0404-0870
Article History
Accepted: 10 September 2024
First Online: 27 September 2024
Declarations
:
: Not applicable.
: M.L. has no conflicts of interest. Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz, and UCB. Tiago Torres is an Editorial Board member of the <i>American Journal of Clinical Dermatology</i>. Tiago Torres was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: The data that support the findings of this article are available from the corresponding author upon reasonable request.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: M.L. and T.T. conceived the idea for the article, performed the data collection and analysis, and drafted and critically revised the manuscript.